News Desk: In keeping with its commitment to ensure access to high quality advanced, and cost-effective diagnostic testing for all. Metropolis Healthcare Ltd a leading diagnostic service provider today announced the launch of Metropolis Innovation Cell focusing on Molecular Genomics, Superspeciality Pathology and Companion Diagnostics Under Innovation Cell, Metropolis is introducing various specialized tests related to Pregnancy Cancer, Infectious Diseases and Transplant Management.
Commenting on the establishment of Metropolis Innovation Celi, Ms. Ameera Shah, Promoter and Managing Director, Metropolis Healthcare Limited said, “As the Innovation and R&D arm of the organization, Metropolis Innovation Cell will focus on the pursuit of fundamental scientific discoveries to catalyze optimal patient management This in turn will fuel the company’s vision and mission of being the most trusted scientific brand and deliver inner health information with compassion, expertise, and honesty to proactively engage with patient and clinicians To further our long-term goals in these areas, we will continue to invest in strengthening our scientific capabilities and expanding our infrastructure to serve patients across the country”
“Metropolis has always been at the forefront in clinical validation of technologies, tests and platforms that directly ensure an accurate timely diagnosis to the patient, including Digital Pathology (Whole Slide Imaging). FDA approved immunotherapy, targeted therapy biomarkers, liquid biopsy, medical genetics, analytical chemistry, pharmacogenomics, COVID diagnostic & prognostic assays etc. After impacting millions of patients, we want to nurture and expand the scope for Oncology, Prenatal testing, Transplant Immunology, Infectious and Chronic Diseases through Next Generation Sequencing and Artificial Intelligence, says Dr. Kirti Chadha, Chief Scientific Officer, Metropolis Healthcare Ltd.
Commenting on the launch of new specialised tests, Dr. Rajat Mukherjee, Zonal Laboratory Head (East), Metropolis Healthcare said: “We have a strong track record of introducing speed tests in the diagnostic industry over the last 40+ years. Our focus is to build our capabilities in different areas and constantly look out for more opportunities to offer affordable testing to patients even in tier 2 and ber 3 cities across the country. Metropolis has been present in West Bengal for more than a decade with various pabent collection centres and pick-up points, catering to 600+ customers. The new specialised tests will be available to patients across all our centre in kolkata.